Zalutsky, M. R., Akabani, G., Friedman, H. S., Cokgor, I., Coleman, R. E., Friedman, A. H., … Bigner, D. D. (2001). Radioimmunotherapy of recurrent glioma patients using alpha-particle emitting astatine-211 labeled chimeric anti-tenascin monoclonal antibody. JOURNAL OF NUCLEAR MEDICINE, 42(5), 121P-122P.

Zalutsky, M. R., G. Akabani, H. S. Friedman, I. Cokgor, R. E. Coleman, A. H. Friedman, R. E. McLendon, X. G. Zhao, K. L. Alston, and D. D. Bigner. “Radioimmunotherapy of recurrent glioma patients using alpha-particle emitting astatine-211 labeled chimeric anti-tenascin monoclonal antibody.” JOURNAL OF NUCLEAR MEDICINE 42, no. 5 (May 1, 2001): 121P-122P.

Zalutsky MR, Akabani G, Friedman HS, Cokgor I, Coleman RE, Friedman AH, et al. Radioimmunotherapy of recurrent glioma patients using alpha-particle emitting astatine-211 labeled chimeric anti-tenascin monoclonal antibody. JOURNAL OF NUCLEAR MEDICINE. 2001 May 1;42(5):121P-122P.

Zalutsky, M. R., et al. “Radioimmunotherapy of recurrent glioma patients using alpha-particle emitting astatine-211 labeled chimeric anti-tenascin monoclonal antibody.” JOURNAL OF NUCLEAR MEDICINE, vol. 42, no. 5, SOC NUCLEAR MEDICINE INC, May 2001, pp. 121P-122P.

Zalutsky MR, Akabani G, Friedman HS, Cokgor I, Coleman RE, Friedman AH, McLendon RE, Zhao XG, Alston KL, Bigner DD. Radioimmunotherapy of recurrent glioma patients using alpha-particle emitting astatine-211 labeled chimeric anti-tenascin monoclonal antibody. JOURNAL OF NUCLEAR MEDICINE. SOC NUCLEAR MEDICINE INC; 2001 May 1;42(5):121P-122P.